Refractory Osteosarcoma: Clinical Trials

3 trials for Refractory Osteosarcoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 recruiting. 3 Phase 2, 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 23Recruiting 3
Phase 12Recruiting 2

Follow Refractory Osteosarcoma: new trials by email Literature Review of Refractory Osteosarcoma trials Research Report on Refractory Osteosarcoma

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Atezolizumab and Cabozantinib for the Treatment of Adolescents and Young Adults With Recurrent or Metastatic Osteosarcoma, TACOS Study
Atezolizumab, Cabozantinib - Locally Advanced Osteosarcoma, Metastatic Osteosarcoma
Phase 2RecruitingM.D. Anderson Cancer Center402023-04-252026-10-06
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
Biospecimen Collection, Dual X-ray Absorptiometry, Tegavivint - Colorectal Carcinoma, Endometrial Carcinoma
Phase 1 / Phase 2RecruitingChildren's Oncology Group1472021-11-082026-08-25
Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma
Onivyde, Talazoparib, Temozolomide - Recurrent Solid Tumor, Recurrent Ewing Sarcoma
Phase 1 / Phase 2RecruitingSt. Jude Children's Research Hospital902021-06-092026-05-19

Narrower conditions

Osteosarcoma (3)  ·  Hepatoblastoma (2)  ·  Neuroblastoma (2)  ·  Sarcoma, Ewing (2)  ·  Wilms Tumor (2)  ·  Carcinoma, Hepatocellular (1)  ·  Colorectal Neoplasms (1)  ·  Desmoid Tumors (1)  ·  Endometrial Neoplasms (1)  ·  Lymphoma, Non-Hodgkin (1)  ·  Melanoma (1)  ·  Neoplasms (1)  ·  Neuroectodermal Tumors, Primitive, Peripheral (1)  ·  Ovarian Neoplasms (1)  ·  Rhabdoid Tumor (1)

Broader conditions

Neoplasms by Histologic Type (3)  ·  Neoplasms, Bone Tissue (3)  ·  Neoplasms, Connective Tissue (3)  ·  Neoplasms, Connective and Soft Tissue (3)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2)  ·  Female Urogenital Diseases (2)  ·  Female Urogenital Diseases and Pregnancy Complications (2)  ·  Genetic Diseases, Inborn (2)  ·  Kidney Diseases (2)  ·  Kidney Neoplasms (2)  ·  Male Urogenital Diseases (2)  ·  Neoplasms (2)  ·  Neoplasms by Site (2)  ·  Neoplasms, Complex and Mixed (2)  ·  Neoplasms, Germ Cell and Embryonal (2)

Interventions

Absorptiometry, Photon (1)  ·  Bone Density (1)  ·  Phantoms, Imaging (1)  ·  Specimen Handling (1)  ·  Temozolomide (1)  ·  X-Rays (1)  ·  atezolizumab (1)  ·  cabozantinib (1)  ·  irinotecan sucrosofate (1)  ·  talazoparib (1)

Sponsors

Children's Oncology Group (1)  ·  M.D. Anderson Cancer Center (1)  ·  St. Jude Children's Research Hospital (1)

Countries

United States (3)  ·  Canada (1)

Top investigators

John A Livingston, MD (1)  ·  Sara Federico, MD (1)  ·  Sarah B Whittle (1)

NIH funding

UM1CA228823 (1)